Please use this identifier to cite or link to this item: https://doi.org/10.1021/mp2000692
Title: Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance
Authors: Johansson, K.
Ito, M.
Schophuizen, C.M.S.
Mathew Thengumtharayil, S.
Heuser, V.D.
Zhang, J.
Shimoji, M.
Vahter, M.
Ang, W.H. 
Dyson, P.J.
Shibata, A.
Shuto, S.
Ito, Y.
Abe, H.
Morgenstern, R.
Keywords: cytostatic drug
drug resistance
glutathione transferase
Issue Date: 3-Oct-2011
Citation: Johansson, K., Ito, M., Schophuizen, C.M.S., Mathew Thengumtharayil, S., Heuser, V.D., Zhang, J., Shimoji, M., Vahter, M., Ang, W.H., Dyson, P.J., Shibata, A., Shuto, S., Ito, Y., Abe, H., Morgenstern, R. (2011-10-03). Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance. Molecular Pharmaceutics 8 (5) : 1698-1708. ScholarBank@NUS Repository. https://doi.org/10.1021/mp2000692
Abstract: Resistance against anticancer drugs remains a serious obstacle in cancer treatment. Here we used novel strategies to target microsomal glutathione transferase 1 (MGST1) and glutathione transferase pi (GSTP) that are often overexpressed in tumors and confer resistance against a number of cytostatic drugs, including cisplatin and doxorubicin (DOX). By synthetically combining cisplatin with a GST inhibitor, ethacrynic acid, to form ethacraplatin, it was previously shown that cytosolic GST inhibition was improved and that cells became more sensitive to cisplatin. Here we show that ethacraplatin is easily taken up by the cells and can reverse cisplatin resistance in MGST1 overexpressing MCF7 cells. A second and novel strategy to overcome GST mediated resistance involves using GST releasable cytostatic drugs. Here we synthesized two derivatives of DOX, 2,4-dinitrobenzenesulfonyl doxorubicin (DNS-DOX) and 4-mononitrobenzenesulfonyl doxorubicin (MNS-DOX) and showed that they are substrates for MGST1 and GSTP (releasing DOX). MGST1 overexpressing cells are resistant to DOX. The resistance is partially reversed by DNS-DOX. Interestingly, the less reactive MNS-DOX was more cytotoxic to cells overexpressing MGST1 than control cells. It would appear that, by controlling the reactivity of the prodrug, and thereby the DOX release rate, selective toxicity to MGST1 overexpressing cells can be achieved. In the case of V79 cells, DOX resistance proportional to GSTP expression levels was noted. In this case, not only was drug resistance eliminated by DNS-DOX but a striking GSTP-dependent increase in toxicity was observed in the clonogenic assay. In summary, MGST1 and GSTP resistance to cytostatic drugs can be overcome and cytotoxicity can be enhanced in GST overexpressing cells. © 2011 American Chemical Society.
Source Title: Molecular Pharmaceutics
URI: http://scholarbank.nus.edu.sg/handle/10635/75722
ISSN: 15438384
DOI: 10.1021/mp2000692
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

27
checked on Jul 21, 2018

WEB OF SCIENCETM
Citations

27
checked on Jun 11, 2018

Page view(s)

50
checked on Jul 6, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.